4//SEC Filing
WISEMAN ANDREW 4
Accession 0001209191-04-027893
CIK 0000920465other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 9:59 PM ET
Size
14.2 KB
Accession
0001209191-04-027893
Insider Transaction Report
Form 4
WISEMAN ANDREW
Sen Dir Investor Relations
Transactions
- Gift
Common Stock
2000-06-14−8,045→ 16,538 total - Other
Common Stock
2004-03-31$1.48/sh+519$768→ 17,057 total - Award
Stock Options (right to buy)
2004-05-21+40,000→ 40,000 totalExercise: $2.96Exp: 2014-05-21→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Shares transferred by reporting person to a trust of which the reporting person is a trustee.
- [F2]Acquired pursuant to the Company?s Employee Stock Purchase Plan.
- [F3]50% of the options vest on the date that the Company receives approval to market its lead drug candidate for the treatment of lupus and 1/24 of the remaining options vest at the end of each month thereafter until all of the options are vested. Notwithstanding the foregoing, if marketing approval is not obtained between the grant date and the three year anniversary of the grant date, then 100% of the options will vest on the three year anniversary of the grant date.
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001237526
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 9:59 PM ET
- Size
- 14.2 KB